Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C11H12O2 |
Molar mass | 176.215 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(what is this?) (verify) |
Centalun was developed by Boehringer Ingelheim in 1962 [1] and is a psycholeptic drug with hypnotic and sedative effects, via allosteric agonism of the GABAA receptor. [2] It was previously used for sedation in medical procedures such as surgery, [3] orthopedics [4] and gynecology, [5] although it is no longer in clinical use. Despite its history of clinical use, centalun was never incorporated into the CSA and therefore remains unregulated as a drug of abuse.
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C11H12O2 |
Molar mass | 176.215 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(what is this?) (verify) |
Centalun was developed by Boehringer Ingelheim in 1962 [1] and is a psycholeptic drug with hypnotic and sedative effects, via allosteric agonism of the GABAA receptor. [2] It was previously used for sedation in medical procedures such as surgery, [3] orthopedics [4] and gynecology, [5] although it is no longer in clinical use. Despite its history of clinical use, centalun was never incorporated into the CSA and therefore remains unregulated as a drug of abuse.